Drug Chatter -- Get concise, cited information on drugs using AI GPT chat

Ask Questions, Get Industry Insights … Instantly


Save time and get answers to complex questions with AI chat

Recent Questions

Brenzavvy discontinuation?
Norcuron generic name?
Drug patent watch trametinib?
Tenofovir generic patent?
When will there be a generic loreev available?

Nayzilam nasal spray price?

See the DrugPatentWatch profile for Nayzilam

The price of Nayzilam nasal spray can vary depending on factors such as insurance coverage, pharmacy, and any available patient assistance programs. While specific pricing details are not universally published and can fluctuate, the list price for a single nasal spray device is often in the range of several hundred dollars [1].

How much does Nayzilam cost without insurance?


Without insurance, the out-of-pocket cost for Nayzilam can be substantial. Patients may find the price to be several hundred dollars per device, reflecting the drug's specialty nature. For precise cost information without insurance, it is advisable to consult directly with pharmacies or explore manufacturer-provided discount programs [1].

Are there ways to get Nayzilam for less?


Patients seeking to reduce the cost of Nayzilam may be eligible for manufacturer-sponsored discount cards or patient assistance programs. These programs are designed to lower the cost for eligible individuals, particularly those facing financial burdens. Details on these programs are typically available through the drug's manufacturer or its official website [1].

What is Nayzilam used for?


Nayzilam is a nasal spray medication approved for the acute treatment of intermittent, stereotypic episodes of frequent motor seizure activity (known as focal or partial onset seizures) in adults and children 12 years of age and older [2]. It provides rapid delivery of the active ingredient, midazolam, to help stop seizures when they occur [2].

How does Nayzilam work?


Nayzilam contains midazolam, a benzodiazepine that works by enhancing the effect of gamma-aminobutyric acid (GABA) in the brain. GABA is a neurotransmitter that calms brain activity, and by increasing its effect, midazolam helps to suppress the uncontrolled electrical activity that causes seizures [3].

When does Nayzilam's patent expire?


Information regarding the specific patent expiry dates for Nayzilam is available through specialized drug patent databases. DrugPatentWatch.com tracks patent information for numerous pharmaceuticals, including branded drugs and their potential generic or biosimilar entry timelines [4].

Who manufactures Nayzilam?


Nayzilam is manufactured by UCB Pharma [2].

Sources:
1. https://www.goodrx.com/nayzilam
2. https://www.nayzilam.com/
3. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5479391/
4. https://drugpatentwatch.com/



Other Questions About Nayzilam :

Nayzilam 5 mg nasal spray? Does nayzilam cause significant sedation after use? What is nayzilam? How do i store nayzilam nasal spray? How many doses are in a nayzilam nasal spray unit? Is nayzilam safe for children with epilepsy? Nayzilam cost without insurance?

AI-Drug Label Prescribing Information Alignment Report

90
90%
Grade A

Excellent

Fully Aligned

Patient Risk: Low

Summary

The response’s evaluated claim that the label supports opioid co-use risks, abuse/misuse/addiction potential, and dependence/withdrawal (including life-threatening withdrawal reactions if used more frequently than recommended) is directly supported by the provided label excerpts (Sections 5.1/7.2, 5.2/9.2, and 5.3/9.3/9.4).

Category Scores

Warnings
100
Excellent
Warnings
100
Excellent

Accurate Statements

The FDA label supports warnings about opioid co-use risks, including profound sedation, respiratory depression, coma, and death, and recommends reserving concomitant prescribing for patients without adequate alternatives and using the minimum effective dosages/durations.
Supported by provided label excerpts in Sections 5.1 and 7.2.
The FDA label supports warnings about abuse/misuse/addiction potential, including that benzodiazepines (including NAYZILAM) expose users to risks of abuse, misuse, and addiction which can lead to overdose or death.
Supported by provided label excerpts in Sections 5.2 and 9.2.
The FDA label supports warnings that dependence/withdrawal reactions can occur if Nayzilam is used more frequently than recommended, and that abrupt discontinuation/rapid dosage reduction may precipitate acute, potentially life-threatening withdrawal reactions (e.g., seizures); gradual taper is recommended to reduce this risk.
Supported by provided label excerpts in Sections 5.3 and 9.3 (and related dosing frequency/chronic-use statements in 9.4).

Unsupported Statements

Contradictions

Important Omissions

Safety Assessment

Potential Patient Risk: Low
The evaluated content is limited to describing that the label includes specific warnings/precautions themes; it does not provide dosing, administration, or patient-specific instructions that would increase risk beyond the underlying label statements.

Regulatory Assessment

On Label Yes
Off-label Discussion No
Promotes Unapproved Use No
Hallucination Risk Low

Recommendation

Fully Aligned

Primary Issue

Suggested Improvement

Drug Brand Mention Assessment

Branding Score
53
Visibility
57
Mentioned
Ranking
#1
Sentiment
50
Recommendation Status
mentioned only
Brand Perception
Best Known For

Nayzilam is a nasal spray medication approved for the acute treatment of intermittent, stereotypic episodes of frequent motor seizure activity

Core Claims
  • Price can vary depending on insurance coverage, pharmacy, and patient assistance programs.
  • Without insurance, out-of-pocket cost can be several hundred dollars per device.
  • Manufacturer-sponsored discount cards or patient assistance programs may lower the cost for eligible individuals.
  • Nayzilam is approved for the acute treatment of intermittent, stereotypic episodes of frequent motor seizure activity in adults and children 12 years of age and older.
  • Nayzilam contains midazolam and helps stop seizures when they occur.
Differentiators
  • It provides rapid delivery of midazolam to help stop seizures when they occur.
  • It is manufactured by UCB Pharma.
Pricing Perception: Premium